Recently, the role of ANK2 in arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition characterized by fibrofatty replacement of the myocardium, ventricular arrhythmias, and sudden cardiac death has come to attention. This evidence concerns the gene ANK2 and Ventricular arrhythmia.